Logotype for National Research Corporation

National Research (NRC) Q1 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for National Research Corporation

Q1 2026 earnings summary

6 May, 2026

Executive summary

  • Q1 2026 achieved record Total Recurring Contract Value (TRCV) of $152.1 million, up 13% year-over-year, with revenue growth for the first time since 2023, reaching $34.8 million.

  • New sales bookings surged over 200% year-over-year, driven by the largest multi-year deal in company history, with customer retention at multi-year highs.

  • Gross retention rate reached its highest level in over seven years, reflecting improved customer engagement and product enhancements.

  • Operating income declined 35% to $5.6 million due to increased executive compensation and technology investments.

  • The company is focused on expanding its platform, driving actionable insights, and supporting healthcare organizations in a challenging market.

Financial highlights

  • Q1 revenue was $34.8 million, up 4% year-over-year, with TRCV at $152.1 million, up 13% year-over-year and 5% sequentially.

  • Adjusted EBITDA was $9.4 million (27% margin), up 230 basis points sequentially but down from 30.8% in the prior year.

  • Adjusted net income was $4.6 million, with adjusted EPS of $0.21, up $0.05 sequentially.

  • Free cash flow rose nearly 50% year-over-year to $5.3 million ($0.24 per share), with free cash flow margin at 15.4%.

  • Net income fell to $3.2 million from $5.8 million year-over-year, with diluted EPS at $0.14.

Outlook and guidance

  • The landmark multi-year deal will be implemented in two phases, with Phase I (Experience platform) going live in Q3 2026 and Phase II (Enablement platform) in Q3 2027.

  • Near-term margin expansion will be limited by implementation costs and a $9.4 million Q2 expense from executive equity award amendments, but margins are expected to expand in Q3 and beyond.

  • Long-term EBITDA margin is targeted to return to the low 30s in the midterm and potentially mid-30s longer term, assuming mid- to high single-digit top-line growth.

  • Management expects existing liquidity and cash flows to be sufficient for foreseeable capital and debt needs.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more